Cargando…

Insights on the Structural Variations of the Furin-Like Cleavage Site Found Among the December 2019–July 2020 SARS-CoV-2 Spike Glycoprotein: A Computational Study Linking Viral Evolution and Infection

The SARS-CoV-2 (SARS2) is the cause of the coronavirus disease 2019 (COVID-19) pandemic. One unique structural feature of the SARS2 spike protein is the presence of a furin-like cleavage site (FLC) which is associated with both viral pathogenesis and host tropism. Specifically, SARS2 spike protein b...

Descripción completa

Detalles Bibliográficos
Autores principales: Cueno, Marni E., Ueno, Miu, Iguchi, Rinako, Harada, Tsubasa, Miki, Yoshifumi, Yasumaru, Kanae, Kiso, Natsumi, Wada, Kanta, Baba, Koki, Imai, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987684/
https://www.ncbi.nlm.nih.gov/pubmed/33777970
http://dx.doi.org/10.3389/fmed.2021.613412
_version_ 1783668661841559552
author Cueno, Marni E.
Ueno, Miu
Iguchi, Rinako
Harada, Tsubasa
Miki, Yoshifumi
Yasumaru, Kanae
Kiso, Natsumi
Wada, Kanta
Baba, Koki
Imai, Kenichi
author_facet Cueno, Marni E.
Ueno, Miu
Iguchi, Rinako
Harada, Tsubasa
Miki, Yoshifumi
Yasumaru, Kanae
Kiso, Natsumi
Wada, Kanta
Baba, Koki
Imai, Kenichi
author_sort Cueno, Marni E.
collection PubMed
description The SARS-CoV-2 (SARS2) is the cause of the coronavirus disease 2019 (COVID-19) pandemic. One unique structural feature of the SARS2 spike protein is the presence of a furin-like cleavage site (FLC) which is associated with both viral pathogenesis and host tropism. Specifically, SARS2 spike protein binds to the host ACE-2 receptor which in-turn is cleaved by furin proteases at the FLC site, suggesting that SARS2 FLC structural variations may have an impact on viral infectivity. However, this has not yet been fully elucidated. This study designed and analyzed a COVID-19 genomic epidemiology network for December 2019 to July 2020, and subsequently generated and analyzed representative SARS2 spike protein models from significant node clusters within the network. To distinguish possible structural variations, a model quality assessment was performed before further protein model analyses and superimposition of the protein models, particularly in both the receptor-binding domain (RBD) and FLC. Mutant spike models were generated with the unique (681)PRRA(684) amino acid sequence found within the deleted FLC. We found 9 SARS2 FLC structural patterns that could potentially correspond to nine node clusters encompassing various countries found within the COVID-19 genomic epidemiology network. Similarly, we associated this with the rapid evolution of the SARS2 genome. Furthermore, we observed that either in the presence or absence of the unique (681)PRRA(684) amino acid sequence no structural changes occurred within the SARS2 RBD, which we believe would mean that the SARS2 FLC has no structural influence on SARS2 RBD and may explain why host tropism was maintained.
format Online
Article
Text
id pubmed-7987684
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79876842021-03-25 Insights on the Structural Variations of the Furin-Like Cleavage Site Found Among the December 2019–July 2020 SARS-CoV-2 Spike Glycoprotein: A Computational Study Linking Viral Evolution and Infection Cueno, Marni E. Ueno, Miu Iguchi, Rinako Harada, Tsubasa Miki, Yoshifumi Yasumaru, Kanae Kiso, Natsumi Wada, Kanta Baba, Koki Imai, Kenichi Front Med (Lausanne) Medicine The SARS-CoV-2 (SARS2) is the cause of the coronavirus disease 2019 (COVID-19) pandemic. One unique structural feature of the SARS2 spike protein is the presence of a furin-like cleavage site (FLC) which is associated with both viral pathogenesis and host tropism. Specifically, SARS2 spike protein binds to the host ACE-2 receptor which in-turn is cleaved by furin proteases at the FLC site, suggesting that SARS2 FLC structural variations may have an impact on viral infectivity. However, this has not yet been fully elucidated. This study designed and analyzed a COVID-19 genomic epidemiology network for December 2019 to July 2020, and subsequently generated and analyzed representative SARS2 spike protein models from significant node clusters within the network. To distinguish possible structural variations, a model quality assessment was performed before further protein model analyses and superimposition of the protein models, particularly in both the receptor-binding domain (RBD) and FLC. Mutant spike models were generated with the unique (681)PRRA(684) amino acid sequence found within the deleted FLC. We found 9 SARS2 FLC structural patterns that could potentially correspond to nine node clusters encompassing various countries found within the COVID-19 genomic epidemiology network. Similarly, we associated this with the rapid evolution of the SARS2 genome. Furthermore, we observed that either in the presence or absence of the unique (681)PRRA(684) amino acid sequence no structural changes occurred within the SARS2 RBD, which we believe would mean that the SARS2 FLC has no structural influence on SARS2 RBD and may explain why host tropism was maintained. Frontiers Media S.A. 2021-03-10 /pmc/articles/PMC7987684/ /pubmed/33777970 http://dx.doi.org/10.3389/fmed.2021.613412 Text en Copyright © 2021 Cueno, Ueno, Iguchi, Harada, Miki, Yasumaru, Kiso, Wada, Baba and Imai. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Cueno, Marni E.
Ueno, Miu
Iguchi, Rinako
Harada, Tsubasa
Miki, Yoshifumi
Yasumaru, Kanae
Kiso, Natsumi
Wada, Kanta
Baba, Koki
Imai, Kenichi
Insights on the Structural Variations of the Furin-Like Cleavage Site Found Among the December 2019–July 2020 SARS-CoV-2 Spike Glycoprotein: A Computational Study Linking Viral Evolution and Infection
title Insights on the Structural Variations of the Furin-Like Cleavage Site Found Among the December 2019–July 2020 SARS-CoV-2 Spike Glycoprotein: A Computational Study Linking Viral Evolution and Infection
title_full Insights on the Structural Variations of the Furin-Like Cleavage Site Found Among the December 2019–July 2020 SARS-CoV-2 Spike Glycoprotein: A Computational Study Linking Viral Evolution and Infection
title_fullStr Insights on the Structural Variations of the Furin-Like Cleavage Site Found Among the December 2019–July 2020 SARS-CoV-2 Spike Glycoprotein: A Computational Study Linking Viral Evolution and Infection
title_full_unstemmed Insights on the Structural Variations of the Furin-Like Cleavage Site Found Among the December 2019–July 2020 SARS-CoV-2 Spike Glycoprotein: A Computational Study Linking Viral Evolution and Infection
title_short Insights on the Structural Variations of the Furin-Like Cleavage Site Found Among the December 2019–July 2020 SARS-CoV-2 Spike Glycoprotein: A Computational Study Linking Viral Evolution and Infection
title_sort insights on the structural variations of the furin-like cleavage site found among the december 2019–july 2020 sars-cov-2 spike glycoprotein: a computational study linking viral evolution and infection
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987684/
https://www.ncbi.nlm.nih.gov/pubmed/33777970
http://dx.doi.org/10.3389/fmed.2021.613412
work_keys_str_mv AT cuenomarnie insightsonthestructuralvariationsofthefurinlikecleavagesitefoundamongthedecember2019july2020sarscov2spikeglycoproteinacomputationalstudylinkingviralevolutionandinfection
AT uenomiu insightsonthestructuralvariationsofthefurinlikecleavagesitefoundamongthedecember2019july2020sarscov2spikeglycoproteinacomputationalstudylinkingviralevolutionandinfection
AT iguchirinako insightsonthestructuralvariationsofthefurinlikecleavagesitefoundamongthedecember2019july2020sarscov2spikeglycoproteinacomputationalstudylinkingviralevolutionandinfection
AT haradatsubasa insightsonthestructuralvariationsofthefurinlikecleavagesitefoundamongthedecember2019july2020sarscov2spikeglycoproteinacomputationalstudylinkingviralevolutionandinfection
AT mikiyoshifumi insightsonthestructuralvariationsofthefurinlikecleavagesitefoundamongthedecember2019july2020sarscov2spikeglycoproteinacomputationalstudylinkingviralevolutionandinfection
AT yasumarukanae insightsonthestructuralvariationsofthefurinlikecleavagesitefoundamongthedecember2019july2020sarscov2spikeglycoproteinacomputationalstudylinkingviralevolutionandinfection
AT kisonatsumi insightsonthestructuralvariationsofthefurinlikecleavagesitefoundamongthedecember2019july2020sarscov2spikeglycoproteinacomputationalstudylinkingviralevolutionandinfection
AT wadakanta insightsonthestructuralvariationsofthefurinlikecleavagesitefoundamongthedecember2019july2020sarscov2spikeglycoproteinacomputationalstudylinkingviralevolutionandinfection
AT babakoki insightsonthestructuralvariationsofthefurinlikecleavagesitefoundamongthedecember2019july2020sarscov2spikeglycoproteinacomputationalstudylinkingviralevolutionandinfection
AT imaikenichi insightsonthestructuralvariationsofthefurinlikecleavagesitefoundamongthedecember2019july2020sarscov2spikeglycoproteinacomputationalstudylinkingviralevolutionandinfection